AM-1221 is a drug that acts as a potent and selective agonist for the cannabinoid receptor CB2 with a Ki of 0.28nM at CB2 and 52.3nM at the CB1 receptor […]
List of articles in "Drug" category - Page 83
SER-601
SER-601 (COR-167) is a drug which acts as a potent and selective cannabinoid CB2 receptor agonist based on a quinolone-3-carboxylic acid core structure with 190x selectivity for CB2 over the […]
Org 27569
Org 27569 is a drug which acts as a potent and selective allosteric modulator of the cannabinoid CB1 receptor. Studies in vitro suggest that it binds to a regulatory site […]
A-796260
A-796260 is a drug developed by Abbott Laboratories that acts as a potent and selective cannabinoid CB2 receptor agonist. Replacing the aromatic 3-benzoyl or 3-naphthoyl group found in most indole […]
GW-842166X
GW-842166X is a drug which acts as a potent and selective cannabinoid CB2 receptor agonist with a novel chemical structure based on a pyrimidine core. It has potent analgesic anti-inflammatory […]
A-834735
A-834735 is a drug developed by Abbott Laboratories that acts as a potent cannabinoid receptor full agonist at both the CB1 and CB2 receptors with a Ki of 12nM at […]
Methiopropamine
Methiopropamine (MPA) is a thiophene ring-based structural analog of methamphetamine originally reported in 1942. Chemically it is not a phenethylamine or amphetamine and is not their functional analog either. It […]
AM-2201
AM-2201 (1-(5-fluoropentyl)-3-(1-naphthoyl)indole) is a research chemical that acts as a potent but nonselective full agonist for the cannabinoid receptor. It is part of the AM series of cannabinoids discovered by […]
8-Cyclopentyl-13-dimethylxanthine
8-Cyclopentyl-13-dimethylxanthine (8-Cyclopentyltheophylline 8-CPT CPX) is a drug which acts as a potent and selective antagonist for the adenosine receptors with some selectivity for the A1 receptor subtype as well as […]
Enprofylline
Enprofylline (3-Propylxanthine) is a xanthine derivative used in the treatment of asthma which acts as a bronchodilator. It acts primarily as a competitive nonselective phosphodiesterase inhibitor with relatively little activity […]